Trials / Unknown
UnknownNCT05369598
Audiological and Quality of Life Outcomes of Anatomy Based Fitting in Patients Implanted by Robot Assisted Cochlear Implant Surgery (RACIS)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated. This study will focus on patients that are already implanted with the HEARO robotic system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Post-operative ABF followed by fitting according to clinical standard | Cochlear implant will be fitted first with anatomy-based fitting for 6 months and followed by default fitting for 2 months. |
| DEVICE | Fitting according to clinical standard followed by post-operative ABF | Cochlear implant will be fitted first with default fitting for 6 months and followed by anatomy-based fitting for 2 months. |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2022-05-11
- Last updated
- 2023-12-12
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05369598. Inclusion in this directory is not an endorsement.